Lite Strategy

Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

Lite Strategyについて

設立

2018

コミュニティ

Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.

資金調達の詳細

資金調達ラウンド金額評価額
Date
投資家
Post-IPO
¥14.74B
--
2025-07-21
--